PHARM Connect Congress 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PHARM Connect Congress 2013


The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013.
The event is bringing together around 500 senior decision-makers from Europe’s leading pharmaceutical and biotechnology companies, giving them the opportunity to share their knowledge and discuss their key priorities.

Most up-to-date market insights PHARM Connect is supported by numerous leading local and regional media partners and associations, an exposure which ensures the regional focus of the congress. Furthermore, the Programme Advisory Committee assures the highest relevance of the conference programme, which will include the most up-to-date market insights into R&D, Production, Packaging, Logistics, Supply Chain and Quality Management-related topics.

Pre-scheduled business meetings

Moreover, it is the perfect setting for local and international solution-providers to present their products and services directly to key decision-makers. Each solution-provider is selected based on requirements and interests stated by attending professionals prior to the event.
Several weeks in advance of the congress the TEG Meeting Scheduler is made available to every solution-provider and delegate attending. On the site they are able to select key presentations, pre-schedule one-to-one meetings and confirm their presence at several additional networking activities, giving them the opportunity to create their own itinerary prior to the congress taking place.

Additional networking activities

Furthermore, additional networking activities such as seated buffet luncheons or the on the first event day provide an excellent opportunity for all participants to network in a more relaxed environment. The event also offers an exclusive opportunity to take part in specially organised plant visits to leading pharmaceutical production plants, available on a first-come, first-serve basis, all arranged prior to the event via the Meeting Scheduler.

Do not miss this opportunity to network and establish connections, exchange ideas and gain knowledge!

Please visit our website to learn more about the Central Eastern European pharmaceutical congress taking place on February 27- 28 2013 at the Corinthia Grand Hotel Royal in the heart of Budapest.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here